It is important to understand whether in the process of receiving experimental injections, our broad-spectrum immunity gets compromised. A few studies came out recently showing that it may be the case, and more research is needed.
Today’s new commercial frontier is the human body – the “body as a platform.” We are being ushered toward a life-time subscription to an artificial immunity service.
People as Software Platforms
A few months ago, I wrote an article about the war on natural immunity and ability, in which I discussed how we were being ushered toward a subscription model under which we would have to obtain a life-time subscription to the artificial immunity service — with boosters from here into infinity.
The notion of a life-time subscription to an artificial immunity service is dystopian, and I was hoping to be wrong. But alas, the messaging around the need for boosters due to waning immunity seems to indicate that this is where we are heading, unless we don’t participate.
The model is based on the “Blue Ocean Strategy,” which is a business strategy that “proposes creating a brand-new market out of thin air and dominating it (a blue ocean) — as opposed to trying to compete in an existing market (an ocean red with blood).”
For example, when the internet was introduced into commercial use, it was a brand-new market and a “blue ocean,” since no such market had existed prior. The introduction of the internet created a whole new “space” that could be monetized in different ways.
Today’s new commercial frontier is the biological realm and the human body, “body as a platform.” In today’s market terms, the human body has the market potential of a natural resource. You know how they say that data is the new oil? If data is the new oil, then we are all data hosts, and we can look forward to being treated like oil reserves.